Application

EMISAR

Emisar Pharma Services LLC

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 06/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90795780
Filing Date: 06/25/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90795780
MARK INFORMATION
*MARK EMISAR
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT EMISAR
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Emisar Pharma Services LLC
*MAILING ADDRESS Corporation Trust Center, 1209 Orange St
*CITY Wilmington
*STATE
(Required for U.S. applicants)
Delaware
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19801
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 035 
*IDENTIFICATION Business consulting and management services in the fields of prescription drugs and cost management of health care; Negotiating contracts with manufacturers of pharmaceuticals to obtain discounts on the purchase of their goods; Business consulting related to clinical trials; Pharmaceutical cost management services and drug utilization review services; Administering pharmacy reimbursement programs and services; Business research and analytics services, including providing analytics to facilitate pharmaceutical innovation
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Technical consulting and research in the field of pharmaceutical studies; Pharmaceutical product evaluation; Providing a portal for pharmaceutical analytics
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Joseph V. Myers III
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Seyfarth Shaw LLP
STREET 1075 Peachtree St. N.E., #2500
CITY Atlanta
STATE Georgia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 30309
PHONE 404-885-1500
EMAIL ADDRESS tmatlanta@seyfarth.com
OTHER APPOINTED ATTORNEY Julia K. Sutherland, Amy A. Abeloff, Stephen D. Lott, Lauren Gregory
CORRESPONDENCE INFORMATION
NAME Joseph V. Myers III
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmatlanta@seyfarth.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE /Julia K. Sutherland/
SIGNATORY'S NAME Julia K. Sutherland
SIGNATORY'S POSITION Attorney of Record Illinois Bar Member
SIGNATORY'S PHONE NUMBER 312-460-5577
DATE SIGNED 06/25/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 06/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90795780
Filing Date: 06/25/2021

To the Commissioner for Trademarks:

MARK: EMISAR (Standard Characters, see mark)
The literal element of the mark consists of EMISAR. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Emisar Pharma Services LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      Corporation Trust Center, 1209 Orange St
      Wilmington, Delaware 19801
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 035:  Business consulting and management services in the fields of prescription drugs and cost management of health care; Negotiating contracts with manufacturers of pharmaceuticals to obtain discounts on the purchase of their goods; Business consulting related to clinical trials; Pharmaceutical cost management services and drug utilization review services; Administering pharmacy reimbursement programs and services; Business research and analytics services, including providing analytics to facilitate pharmaceutical innovation
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Technical consulting and research in the field of pharmaceutical studies; Pharmaceutical product evaluation; Providing a portal for pharmaceutical analytics
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Joseph V. Myers III. Other appointed attorneys are Julia K. Sutherland, Amy A. Abeloff, Stephen D. Lott, Lauren Gregory. Joseph V. Myers III of Seyfarth Shaw LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1075 Peachtree St. N.E., #2500
      Atlanta, Georgia 30309
      United States
      404-885-1500(phone)
      tmatlanta@seyfarth.com

Joseph V. Myers III submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Joseph V. Myers III
       PRIMARY EMAIL FOR CORRESPONDENCE: tmatlanta@seyfarth.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Julia K. Sutherland/   Date: 06/25/2021
Signatory's Name: Julia K. Sutherland
Signatory's Position: Attorney of Record Illinois Bar Member
Signatory's Phone Number: 312-460-5577
Signature method: Sent to third party for signature
Payment Sale Number: 90795780
Payment Accounting Date: 06/25/2021

Serial Number: 90795780
Internet Transmission Date: Fri Jun 25 15:44:03 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XX.XX-202106251544035601
62-90795780-7807239aaf4a5cc49c84c1b147fe
b5929bbf0de78a0629f4ff310ece094ca8487a9-
DA-44022739-20210625145811410243

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed